PPP1R1B and lung adenocarcinoma: As assessed by Kaplan–Meier survival curve, we observed that patients with high t-DARPP to DARPP-32 ratio showed substantially decreased survival relative to lung adenocarcinoma patients with low t-DARPP expression (Fig. 8b).